Primaquine or tafenoquine for preventing malaria in people travelling to or living in endemic areas

[1]  G. Benelli,et al.  Declining malaria, rising of dengue and Zika virus: insights for mosquito vector control , 2016, Parasitology Research.

[2]  S. D. Fernando,et al.  Tafenoquine for preventing relapse in people with Plasmodium vivax malaria , 2015, The Cochrane database of systematic reviews.

[3]  C. Rodrigo,et al.  Primaquine in vivax malaria: an update and review on management issues , 2011, Malaria Journal.

[4]  S. Meshnick,et al.  Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment , 2011, PloS one.

[5]  S. D. Fernando,et al.  Chemoprophylaxis in malaria: drugs, evidence of efficacy and costs. , 2011, Asian Pacific journal of tropical medicine.

[6]  P. Leggat,et al.  Randomized, Double-Blind Study of the Safety, Tolerability, and Efficacy of Tafenoquine versus Mefloquine for Malaria Prophylaxis in Nonimmune Subjects , 2009, Antimicrobial Agents and Chemotherapy.

[7]  Ernest Beutler,et al.  The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. , 2009, Blood cells, molecules & diseases.

[8]  R. Moreira,et al.  Primaquine revisited six decades after its discovery. , 2009, European journal of medicinal chemistry.

[9]  J. Carmona-Fonseca,et al.  Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment. , 2009, The American journal of tropical medicine and hygiene.

[10]  D. Kocisko,et al.  The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  A. Omari,et al.  Primaquine for preventing relapses in people with Plasmodium vivax malaria. , 2007, The Cochrane database of systematic reviews.

[12]  A. Magill,et al.  Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. , 2006, The American journal of tropical medicine and hygiene.

[13]  K. Rieckmann,et al.  Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. , 2004, The Journal of infectious diseases.

[14]  K. Rieckmann,et al.  Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15]  V. Sharma,et al.  Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India. , 2001, Annals of tropical medicine and parasitology.

[16]  Paul M. Simo.  Summary and Key Points , 2000 .

[17]  M. Bouma,et al.  Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  P. Garnham,et al.  Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note. , 1980, British medical journal.